Paranasal Sinus Neoplasms Completed Phase 2 Trials for Hydroxyurea (DB01005)

Also known as: Paranasal sinus neoplasm / Tumor of nasal sinus

IndicationStatusPhase
DBCOND0031455 (Paranasal Sinus Neoplasms)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00462735Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck CancerTreatment